The Medicines and Healthcare Products Regulatory Agency today announced the re-appointment of Mr. John Williams CBE as a non-executive director of the Agency Board. Mr. Williams has a distinguished background as a consultant specialist in oral and maxillofacial surgery. He is a former president of the British, the European and the International Association of Oral and Maxillofacial Surgery. He is also the interim chairman of the Committee on the Safety of Devices.
 

Professor Sir Gordon Duff, MHRA Chairman said: “I am most grateful to John for accepting his re-appointment to the Agency Board. His expertise and clinical experience will ensure that the board has the right balance of knowledge and skills, particularly in the area of medical devices, as we move forward with innovative developments and new challenges.”
 

The Agency Board is primarily responsible for advising on the strategic development of the Agency and ensuring that targets set out in our business plan, and endorsed by ministers are met. It currently consists of eight non-executive directors and the chief executive officer. A recruitment campaign is now underway to increase the Board’s membership to nine. This is to take into account the Agency’s expanded role following the addition of the National Institute for Biological Standards and Control (NIBSC) in April and the forthcoming retirement of two of its non-executive directors. Among the skills being sought for the new Agency Board will be a background in epidemiology/bio-statistics, bio-medical engineering and/or medical devices innovation, and clinical academia.

 

Notes to Editor

 

  • Non-executive directors’ appointments are for a time commitment of between two and three days per month and are remunerated at a rate of £7,833 per annum.
  • Appointments to the Agency Board are made on merit and political activity plays no part in the selection process. However, in accordance with the original Nolan recommendations, there is a requirement for appointees’ political activity (if declared) to be made public. Mr Williams has not declared any political activity.
  • Full list of Agency Board members.
  • The MHRA is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe. Underpinning all our work lies robust and fact-based judgements to ensure that the benefits justify any risks. The MHRA is a centre of the Medicines and Healthcare Products Regulatory Agency which also includes the National Institute for Biological Standards and Control (NIBSC) and the Clinical Practice Research Datalink (CPRD). The Medicines and Healthcare Products Regulatory Agency is an executive agency of the Department of Health.

 

Posted on the UK MHRA website on 23 May 2013